BUSSOLINO, Federico
 Distribuzione geografica
Continente #
NA - Nord America 14.174
EU - Europa 9.490
AS - Asia 5.523
AF - Africa 76
OC - Oceania 31
SA - Sud America 28
Continente sconosciuto - Info sul continente non disponibili 7
Totale 29.329
Nazione #
US - Stati Uniti d'America 13.933
CN - Cina 2.940
IT - Italia 1.548
IE - Irlanda 1.254
SG - Singapore 1.230
UA - Ucraina 1.145
SE - Svezia 1.122
DE - Germania 1.107
FR - Francia 909
FI - Finlandia 730
KR - Corea 613
GB - Regno Unito 601
PL - Polonia 339
CA - Canada 229
VN - Vietnam 205
AT - Austria 184
DK - Danimarca 149
JP - Giappone 125
RU - Federazione Russa 93
BE - Belgio 85
IN - India 79
ID - Indonesia 78
NL - Olanda 73
HK - Hong Kong 67
SN - Senegal 60
TW - Taiwan 42
TR - Turchia 36
CH - Svizzera 26
IR - Iran 26
AU - Australia 24
GR - Grecia 23
NO - Norvegia 21
SA - Arabia Saudita 19
ES - Italia 17
BR - Brasile 13
UZ - Uzbekistan 13
MX - Messico 12
RO - Romania 12
PH - Filippine 9
TH - Thailandia 9
CL - Cile 8
BY - Bielorussia 7
EU - Europa 7
LT - Lituania 7
NZ - Nuova Zelanda 7
PT - Portogallo 7
IQ - Iraq 6
ZA - Sudafrica 6
AL - Albania 5
CZ - Repubblica Ceca 5
IL - Israele 5
RS - Serbia 5
PK - Pakistan 4
AR - Argentina 3
EE - Estonia 3
EG - Egitto 3
HU - Ungheria 3
LK - Sri Lanka 3
MY - Malesia 3
NG - Nigeria 3
BG - Bulgaria 2
HR - Croazia 2
KZ - Kazakistan 2
MD - Moldavia 2
MO - Macao, regione amministrativa speciale della Cina 2
MU - Mauritius 2
PE - Perù 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CO - Colombia 1
GE - Georgia 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
MM - Myanmar 1
MN - Mongolia 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
VE - Venezuela 1
Totale 29.329
Città #
Beijing 1.886
Chandler 1.789
Dublin 1.250
Santa Clara 1.136
Singapore 963
Ann Arbor 804
Jacksonville 734
Houston 640
Villeurbanne 598
Fairfield 573
Ashburn 439
Medford 417
Torino 416
Princeton 410
Woodbridge 410
Dearborn 384
Columbus 346
Nyköping 346
Wilmington 339
Warsaw 320
Milan 210
Seattle 204
Cambridge 198
Vienna 175
Boston 158
Turin 144
Boardman 140
Pisa 140
Fremont 138
Toronto 138
Dong Ket 116
Guangzhou 99
Verona 84
Shanghai 77
Jakarta 76
Nanjing 75
Brussels 70
Falls Church 68
Norwalk 65
Redwood City 65
Hefei 60
San Mateo 53
Helsinki 51
Hangzhou 48
Lachine 48
Jinan 44
New York 44
Kunming 43
San Diego 38
Munich 36
Düsseldorf 31
Washington 31
Taipei 30
Hong Kong 28
Los Angeles 28
Wuhan 28
Rome 26
Padova 24
London 23
Xian 23
Tokyo 21
Changsha 20
Monmouth Junction 20
Pune 20
Redmond 20
Zhengzhou 20
Amsterdam 19
Chengdu 18
Fuzhou 18
Hebei 18
Mountain View 18
Saint Petersburg 18
Nanchang 17
Phoenix 17
Sanayi 17
Seoul 17
Nuremberg 16
Chicago 15
San Jose 15
Shenyang 15
Dammam 14
Ottawa 14
Piemonte 14
Upper Marlboro 14
Stavanger 13
Florence 12
Frankfurt am Main 12
Las Vegas 12
Tianjin 12
Bruehl 11
Dallas 11
Genoa 11
Tappahannock 11
Ardabil 10
Auburn Hills 10
Central District 10
Chongqing 10
Zurich 10
Bangkok 9
Detroit 9
Totale 17.965
Nome #
Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment 472
Liver X receptor activation reduces angiogenesis by impairing lipid raft localization and signaling of vascular endothelial growth factor receptor-2 408
BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS Mutant Colorectal Cancer 335
Semaphorins in cardiovascular medicine. 295
Wnt/IL-1β/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5 294
A transient kinetic study between signaling proteins: the case of the MEK–ERK interaction 282
Potential diagnostic and prognostic role of micro-environment in malignant pleural mesothelioma 271
CCL16 activates an angiogenic program in vascular endothelial cells 259
Diacylglycerol kinase-alpha phosphorylation by Src on Y335 is required for activation, membrane recruitment and Hgf-induced cell motility. 245
Bioengineered tumoral microtissues recapitulate desmoplastic reaction of pancreatic cancer 223
VEGF blockade enhances the antitumor effect of BRAFV600E inhibition 218
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination 196
A regulatory microRNA network controls endothelial cell phenotypic switch during sprouting angiogenesis 194
Modulation of Angiopoietin 2 release from endothelial cells and angiogenesis by the synaptic protein Neuroligin 2 187
The neuronal pentraxin-2 pathway is an unrecognized target in human neuroblastoma which also offers prognostic value in patients 186
A peptide from the extracellular region of the synaptic protein α Neurexin stimulates angiogenesis and the vascular specific tyrosine kinase Tie2 183
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice 180
PI3K/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations 172
Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia 168
Real-time monitoring of cell protrusion dynamics by impedance responses 161
Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity 158
TFEB controls vascular development by regulating the proliferation of endothelial cells 156
Simplification of a complex signal transduction model using invariants and flow equivalent servers 154
Differential regulation of neurexin at glutamatergic and GABAergic synapses. 153
Fluorescence anisotropy analysis of protein-antibody interaction 146
Neuroligin 1 induces blood vessel maturation by cooperating with the α6 integrin. 145
A study of the interaction between fluorescein sodium salt and bovine serum albumin by steady-state fluorescence 144
Consensus guidelines for the use and interpretation of angiogenesis assays 143
SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets. 137
Nervous vascular parallels: axon guidance and beyond 136
Activation of endothelial guanylate cyclase inhibits cellular reactivity. 131
A complex of α6 integrin and E-cadherin drives the liver metastasis of colorectal cancer cells by a physical and functional interaction with hepatic angiopoietin-like 6 131
Abstract 5620: Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings 128
Effect of inhibiting the sterol biosynthesis pathway and the cholesterol content in the regulation of angiogenesis in vitro and in vivo 126
KRAS-driven metabolic rewiring reveals novel actionable targets in cancer 126
A computational model for eukaryotic directional sensing 121
Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program 120
The miR-126 regulates Angiopoietin-1 signaling and vessel maturation by targeting p85β 119
Tumor progression: the neuronal input 119
Abstract 1163: Microenvironment targets in KRAS-mutated metastatic colorectal cancer 118
Biological aspects of tumour angiogenesis 117
Adaptor ShcA protein binds tyrosine kinase Tie2 receptor and regulates migration and sprouting but not survival of endothelial cells 117
Evidence for a role of the Na+/H+ exchanger in the colony-stimulating-factor-induced ornithine decarboxylase activity and proliferation of the human cell line M-07e. 116
Activation of diacylglycerol kinase alpha is required for VEGF-induced angiogenic signaling in vitro 116
MicroRNA-mediated regulatory circuits: outlook and perspectives 114
A novel mechanism of HIV-1 entry into host cells and peptides inhibiting this mechanism 113
Activation of JAK2 in human vascular endothelial cells by granulocyte-macrophage colony-stimulating factor. 113
A study of the interaction between fluorescein sodium salt and bovine serum albumin by steady-state fluorescence 113
Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1. 112
Human alpha-thrombin induces phosphoinositide turnover and Ca2+ movements in cultured human umbilical vein endothelial cells. 111
HIV-protease inhibitors impair angiogenesis and tumor progression by targeting MMP-9 in a transgenic mouse model of spontaneous cervical carcinogenesis 111
An anti-inflammatory protein secreted from the rat seminal vesicle epithelium inhibits the synthesis of platelet-activating factor and the release of arachidonic acid and prostacyclin. 110
On the use of stochastic Petri nets in the analysis of Signal Transduction Pathways for Angiogenesis process 110
IL-12-dependent innate immunity arrests endothelial cells in G0-G1 phase by a p21(Cip1/Waf1)-mediated mechanism. 109
Angiogenesis: prognostic significance in laryngeal cancer. 108
Human endothelial cells are targets for platelet-activating factor (PAF).Activation of alpha and beta protein kinase C isozymes in endothelial cells stimulated by PAF. 108
Human GM-CSF in vivo: identification of the target cells and of their kinetics of response. 107
Vasculogenic potential of long term repopulating cord blood progenitors 106
Selected cytokines promote the synthesis of platelet-activating factor in vascular endothelial cells: comparison between tumor necrosis factor alpha and beta and interleukin-1. 105
3-phosphoinositide-dependent kinase 1 controls breast tumor growth in a kinase-dependent but Akt-independent manner 105
A new computational approach to analyze human protein complexes and predict novel protein interactions 104
Gene expression profiling of HMGB1-stimulated endothelial cells: a balancing act between angiogenesis and inflammation 102
Integrins team up with tyrosine kinase receptors and plexins to control angiogenesis 102
Small GTPase Rab5 participates in chromosome congression and regulates localization of the centromere-associated protein CENP-F to kinetochores. 102
Role of Na+/H+ exchange in the granulocyte-macrophage colony-stimulating factor-dependent growth of a leukemic cell line M07e. 101
Bloch surface wave enhanced biosensor for the direct detection of Angiopoietin-2 tumor biomarker in human plasma 100
Platelet-activating factor (PAF) in experimentally-induced rabbit acute serum sickness: role of basophil-derived PAF in immune complex deposition 99
Class 3 semaphorins: physiological vascular normalizing agents for anti-cancer therapy 99
Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy 99
The R-Ras/RIN2/Rab5 complex controls endothelial cell adhesion and morphogenesis via active integrin endocytosis and Rac signaling 99
Semaphorin 3A blocks cancer invasiveness and metastases dissemination induced by theanti-angiogenic therapy by overcoming tumor hypoxia 98
Unraveling the influence of endothelial cell density on VEGF-A signaling 98
MRCKalpha is activated by caspase cleavage to assemble an apical actin ring for epithelial cell extrusion 97
A simulation environment for directional sensing as a phase separation process 96
LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms 95
Ex vivo-expanded bone marrow CD34(+) for acute myocardial infarction treatment: in vitro and in vivo studies. 95
Semaphorin 3A Regulates Angiogenesis and Tumor Progression in Mouse Models of Tumorigenesis 95
S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells. 94
The role of redox system in metastasis formation 94
Semaphorin 4A Exerts a Proangiogenic Effect by Enhancing Vascular Endothelial Growth Factor-A Expression in Macrophages 93
SPAD aptasensor for the detection of circulating protein biomarkers 93
Multifaceted activities of transcription factor eb in cancer onset and progression 93
Identification of CD36 molecular features required for its in vitro angiostatic activity. 92
A possible role for nitric oxide in modulating the functional cyclosporine toxicity by arginine. 92
PDK1-mediated activation of MRCK  regulates directional cell migration and lamellipodia retraction 92
Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1 91
Besides adhesion: new perspectives of integrin functions in angiogenesis 91
Fluorescence anisotropy analysis of protein-antibody interaction 91
Nanomedicine for Imaging and Therapy of Pancreatic Adenocarcinoma 91
Tumor necrosis factor induces contraction of mesangial cells and alters their cytoskeletons. 90
Cell surface-associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein. 90
c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. 90
Role of Na+/H+ exchange in thrombin-induced platelet-activating factor production by human endothelial cells. 90
Neuropilin-1/GIPC1 signaling regulates alpha5beta1 integrin traffic and function in endothelial cells 90
Semaphorin 3A blocks tumor invasion, inhibits metastases formation and prevents the resistance to the anti-angiogenic therapies by overcoming cancer hypoxia. 90
HIV-protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction 90
Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival 88
Platelet arachidonic acid metabolism in patients with cardiovascular disorders. 88
Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils. 88
Recombinant AAV vector encoding human VEGF165 enhances wound healing. 87
Totale 13.630
Categoria #
all - tutte 95.174
article - articoli 0
book - libri 0
conference - conferenze 7.174
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.348


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.683 0 0 0 0 0 642 502 259 468 338 293 181
2020/20213.287 250 220 321 204 319 172 258 115 467 330 215 416
2021/20223.657 173 176 174 190 134 180 325 182 135 319 778 891
2022/20235.271 591 374 110 461 558 1.307 436 344 592 94 284 120
2023/20242.079 312 404 132 128 125 192 71 87 21 99 164 344
2024/20253.614 68 578 251 670 1.662 385 0 0 0 0 0 0
Totale 30.353